{
 "drug": "Activated Charcoal Oral Suspension",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "05/15/2026",
 "dayN": 102,
 "cat": "Other",
 "companies": [
  "Padagis US LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "05/15/2026",
   "update_type": "New",
   "initial_posting_date": "05/15/2026",
   "package_ndc": "0574-0521-76",
   "generic_name": "Activated Charcoal Oral Suspension",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "M023"
    ],
    "brand_name": [
     "ACTIDOSE AQUA"
    ],
    "generic_name": [
     "ACTIVATED CHARCOAL"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-0521"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ACTIVATED CHARCOAL"
    ],
    "rxcui": [
     "309150",
     "1251411"
    ],
    "spl_id": [
     "bd250d66-b8ea-4cab-a8f2-d2913a157fc5"
    ],
    "spl_set_id": [
     "c85dc235-3f42-4361-9bd2-1aaff798ad75"
    ],
    "package_ndc": [
     "0574-0521-25",
     "0574-0521-74",
     "0574-0521-76"
    ],
    "unii": [
     "2P3VWU3H10"
    ]
   },
   "update_date": "05/15/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/15/2026",
   "update_type": "New",
   "initial_posting_date": "05/15/2026",
   "package_ndc": "0574-0521-74",
   "generic_name": "Activated Charcoal Oral Suspension",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "M023"
    ],
    "brand_name": [
     "ACTIDOSE AQUA"
    ],
    "generic_name": [
     "ACTIVATED CHARCOAL"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-0521"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ACTIVATED CHARCOAL"
    ],
    "rxcui": [
     "309150",
     "1251411"
    ],
    "spl_id": [
     "bd250d66-b8ea-4cab-a8f2-d2913a157fc5"
    ],
    "spl_set_id": [
     "c85dc235-3f42-4361-9bd2-1aaff798ad75"
    ],
    "package_ndc": [
     "0574-0521-25",
     "0574-0521-74",
     "0574-0521-76"
    ],
    "unii": [
     "2P3VWU3H10"
    ]
   },
   "update_date": "05/15/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/15/2026",
   "update_type": "New",
   "initial_posting_date": "05/15/2026",
   "package_ndc": "0574-0521-25",
   "generic_name": "Activated Charcoal Oral Suspension",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "M023"
    ],
    "brand_name": [
     "ACTIDOSE AQUA"
    ],
    "generic_name": [
     "ACTIVATED CHARCOAL"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-0521"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ACTIVATED CHARCOAL"
    ],
    "rxcui": [
     "309150",
     "1251411"
    ],
    "spl_id": [
     "bd250d66-b8ea-4cab-a8f2-d2913a157fc5"
    ],
    "spl_set_id": [
     "c85dc235-3f42-4361-9bd2-1aaff798ad75"
    ],
    "package_ndc": [
     "0574-0521-25",
     "0574-0521-74",
     "0574-0521-76"
    ],
    "unii": [
     "2P3VWU3H10"
    ]
   },
   "update_date": "05/15/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/15/2026",
   "update_type": "New",
   "initial_posting_date": "05/15/2026",
   "package_ndc": "0574-0520-74",
   "generic_name": "Activated Charcoal Oral Suspension",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "M023"
    ],
    "brand_name": [
     "ACTIDOSE"
    ],
    "generic_name": [
     "ACTIVATED CHARCOAL"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-0520"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ACTIVATED CHARCOAL"
    ],
    "rxcui": [
     "309150",
     "1251411"
    ],
    "spl_id": [
     "cf3da077-fe7d-4685-8c5c-f773bc88c88d"
    ],
    "spl_set_id": [
     "76e4fe6a-afd4-4f68-b12d-0b094f750615"
    ],
    "package_ndc": [
     "0574-0520-74",
     "0574-0520-76"
    ],
    "unii": [
     "2P3VWU3H10"
    ]
   },
   "update_date": "05/15/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "05/15/2026",
   "update_type": "New",
   "initial_posting_date": "05/15/2026",
   "package_ndc": "0574-0520-76",
   "generic_name": "Activated Charcoal Oral Suspension",
   "contact_info": "866-634-9120",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "M023"
    ],
    "brand_name": [
     "ACTIDOSE"
    ],
    "generic_name": [
     "ACTIVATED CHARCOAL"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-0520"
    ],
    "product_type": [
     "HUMAN OTC DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ACTIVATED CHARCOAL"
    ],
    "rxcui": [
     "309150",
     "1251411"
    ],
    "spl_id": [
     "cf3da077-fe7d-4685-8c5c-f773bc88c88d"
    ],
    "spl_set_id": [
     "76e4fe6a-afd4-4f68-b12d-0b094f750615"
    ],
    "package_ndc": [
     "0574-0520-74",
     "0574-0520-76"
    ],
    "unii": [
     "2P3VWU3H10"
    ]
   },
   "update_date": "05/15/2026",
   "therapeutic_category": [
    "Other"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  }
 ]
}